Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR5A | P47898 | 4/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HTR2B | P41595 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
| ▸ | NOS2 | P35228 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2828597 | 0.83 | IDO1 (0.51) | LMNAMAPTIDO1ALDH1A1TP53 | |
| SCHEMBL12165459 | 0.83 | HTR5A (0.37) | HTR5ALMNAMAPTIDO1MEN1 | |
| SCHEMBL31728057 | 0.83 | IDO1 (0.51) | LMNAMAPTIDO1ALDH1A1TP53 | |
| SCHEMBL23044014 | 0.80 | MAPT (0.44) | LMNAMAPTIDO1MEN1KMT2A | |
| SCHEMBL7918631 | 0.79 | CYP1A2 (0.48) | LMNAMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL3907143 | 0.77 | CHEK1 (0.50) | LMNAMAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL8539518 | 0.76 | ALDH1A1 (0.47) | IDO1ALDH1A1EGFRTSHR | |
| SCHEMBL4430050 | 0.74 | IDO1 (0.51) | LMNAMAPTIDO1MEN1KMT2A | |
| SCHEMBL5507339 | 0.74 | GAA (0.49) | HTR5ALMNAMAPTMEN1KMT2A | |
| SCHEMBL15913307 | 0.74 | CHRNA7 (0.43) | HTR5ALMNAMAPTMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240215439-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-06-27 | — | — | US | disclosed |
| US-20170263871-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE | TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2017-09-14 | — | — | US | disclosed |
| US-20170263871-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE | TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2017-09-14 | — | — | US | disclosed |
| US-20150236272-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME | DOOSAN CORPORATION (KR) | 2015-08-20 | — | — | US | disclosed |
| US-20120289884-A1 | Fused Ring Diarylamino Photosensitizers for Phototherapy | MALLINCKRODT LLC (US) | 2012-11-15 | — | — | US | disclosed |
| US-20120289884-A1 | Fused Ring Diarylamino Photosensitizers for Phototherapy | MALLINCKRODT LLC (US) | 2012-11-15 | — | — | US | disclosed |
| US-20120289884-A1 | Fused Ring Diarylamino Photosensitizers for Phototherapy | MALLINCKRODT LLC (US) | 2012-11-15 | — | — | US | disclosed |
| US-4466080-A | Three-dimensional patterned media | FORMIGRAPHIC ENGINE CORPORATION (US) | 1984-08-14 | — | — | US | disclosed |
| US-4333165-A | Three-dimensional pattern making methods | FORMIGRAPHIC ENGINE CORPORATION (US) | 1982-06-01 | — | — | US | disclosed |
| US-4288861-A | Three-dimensional systems | FORMIGRAPHIC ENGINE CORPORATION (US) | 1981-09-08 | — | — | US | disclosed |
| US-4078229-A | Three dimensional systems | SWANSON WYN K | 1978-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240215439-A1 | ORGANIC MOLECULES FOR OPTOELECTRONIC DEVICES | OCIAD2, OR10J3, EPCAM | HTR5A 4651/4885LMNA 1482/4885MAPT 2995/4885 |
| US-20170263871-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL AND ORGANIC OPTOELECTRONIC DEVICE | OR10J3, RPS10, OR51E2 | HTR5A 3507/4885LMNA 1723/4885MAPT 3830/4885 |
| US-20150236272-A1 | NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THESAME | INMT, IDO1, IDO2 | HTR5A 78/4885LMNA 2754/4885MAPT 673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.